Margaret Foster Riley
University of Virginia
Margaret Foster Riley is a professor of law in the School of Law, professor of public health sciences in the School of Medicine, and professor of public policy in the Batten School of Leadership and Public Policy at the University of Virginia. Her research focuses on human subjects research law and ethics, biotechnology, health care regulation, and food and drug law. She serves as chair of the university’s Embryonic Stem Cell Research Oversight Committee and as legal advisor to the Health Sciences Institutional Review Board, and is a member of the executive committee of the Center for Health Policy. Prior to joining the University of Virginia, Ms. Riley was an associate with Pepper Hamilton & Scheetz in Philadelphia, where she worked primarily in complex securities, commercial, and mass tort litigation. Prior to that position, she was a litigation associate with Rogers & Wells in New York. She served on the National Research Council’s Committee on Revisions to the Common Rule for the Protection of Human Subjects in Research in the Behavioral and Social Sciences, and has advised numerous committees of the Institute of Medicine and the Virginia Bar. Ms. Riley received a J.D. from Columbia University.
Daniela B. Friedman
University of South Carolina
Daniela B. Friedman is an associate professor in the Department of Health Promotion, Education, and Behavior at the Arnold School of Public Health of the University of South Carolina. She is also a core faculty member of the university’s Statewide Cancer Prevention and Control Program. Dr. Friedman uses both qualitative and quantitative methods to evaluate how people access, understand, and use information on disease risk and prevention. Her research examines individual and social influences on health comprehension, and she studies a variety of innovative strategies for the development and delivery of accurate, language-appropriate, and culturally sensitive health information. She received a Ph.D. in health studies and gerontology from the University of Waterloo in Canada.
Diane R. Gold
Harvard School of Public Health
Diane R. Gold is a professor in the Department of Environmental Health in the School of Public Health at Harvard University, professor of medicine at Harvard Medical School, and associate physician at Brigham and Women’s Hospital. Dr. Gold’s research focuses on the relationships between environmental exposures and the incidence or severity of respiratory diseases, including asthma. The environmental exposures considered include indoor allergens, such as fungi, smoking, and outdoor ozone and particles. She investigates the environmental exposures that may explain socioeconomic, cultural, and gender differences which have been observed in asthma severity. These include perinatal exposures and family stress as well as exposure to the allergens and pollutants mentioned above. She is also interested in the cardiopulmonary effects of particles on the elderly and she has collaborated in research involving controlled human exposures. Dr. Gold served on the Institute of Medicine’s Committee on an Assessment of Asthma and Indoor Air Quality. She received an M.D. from the University of Connecticut School of Medicine.
Lewis R. Goldfrank
New York University Langone Medical Center
Lewis R. Goldfrank (IOM) is chair and Herbert W. Adams Professor of the Department of Emergency Medicine at New York University, and medical director of the New York City Health Department’s Poison Center. Dr. Goldfrank has worked at the Bellevue Hospital Center and New York University’s Medical Center for more than thirty years. He has served on multiple Institute of Medicine (IOM) committees, including the Committee on Personal Protective Equipment for Healthcare Workers in the Workplace Against Novel H1N1 Influenza A. He currently serves as a member of the IOM’s Board on Health Sciences Policy and IOM’s Forum on Medical and Public Health Preparedness for Catastrophic Events. He received an M.D. from the University of Brussels Medical School. He was elected to the IOM in 1996.
Nancy E. Lane
University of California, Davis Health System
Nancy E. Lane (IOM) is an Endowed Professor of Medicine and Rheumatology at the University of California at Davis. She is also director of the Center for Musculoskeletal Health and Aging Research and director of the K12 NIH Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) program. She is principal investigator of the NIH funded Program on Sex Differences in Musculoskeletal Diseases Across the Lifespan at the University of California at Davis School of Medicine. Dr. Lane was president of the board of the United States Bone and Joint Decade and she co-led the International Bone and Joint Decade Conference in Washington, DC. She received an M.D. from the University of California at San Francisco School of Medicine. Dr. Lane was elected to the IOM in 2013.
New York University School of Medicine
Morton Lippmann is a research professor in the Department of Environmental Medicine at New York University’s School of Medicine. Dr. Lippmann’s research has involved a series of studies that seek to identify the physical and chemical components of airborne particles responsible for observed health effects, including subchronic exposures to concentrated fine particles in a mouse model of atherosclerosis, and observational studies of human populations for association of acute and cumulative responses to exposures in the general atmospheric environment. Dr. Lippmann has served on several National Research Council committees, including the Committee on Air Quality in Passenger Cabins of Commercial Aircraft, the Committee on Toxicology, and the Committee on Research and Peer Review in EPA. He received a Ph.D. in environmental health science from New York University.
Murray A. Mittleman
Murray A. Mittleman is an associate professor in the Department of Epidemiology at the Harvard School of Public Health and an associate professor of medicine at the Harvard Medical School. He is the director of the Cardiovascular Epidemiology Research Unit at the Beth Israel Deaconess Medical Center; vice-chair of the Committee on Clinical Investigations, which serves as the Institutional Review Board, at the Beth Israel Deaconess Medical Center; and chair of the Master of Public Health program at the Harvard School of Public Health. Dr. Mittleman’s applied research focuses on behavioral and environmental determinants of acute cardiovascular events and their prognosis. He received an M.D. from McGill University and an M.P.H. and Dr.P.H. in epidemiology from the School of Public Health at Harvard University.
Washington University School of Medicine
Philip Needleman (NAS/IOM) was elected to the National Academy of Sciences in1987 and to the Institute of Medicine in 1993. He was a professor and chair of the Department of Pharmacology at Washington University Medical School (1976-1989) and chief scientist and head of R&D for Monsanto/Searle/Pharmacia (1989-2003). He was interim president of the Donald Danforth Plant Science Center (2009-10) and interim president and CEO of the St Louis Science Center (2010-11). He has served on the NAS council, chaired NAS Section 23, and served on the National Research Council’s Division of Earth and Life Studies. Dr. Needleman received a Ph.D. in pharmacology from the University of Maryland at College Park.
Robert F. Phalen
University of California, Irvine
Robert F. Phalen is co-director of the Air Pollution Health Effects Laboratory, professor in the Department of Medicine, and professor in the Center for Occupational and Environmental Health at the University of California, Irvine (UCI) School of Medicine. In 1972, Dr. Phalen joined the College of Medicine at UCI to establish the Air Pollution Health Effects Laboratory, which conducts studies relating to the toxicology of air pollutants. His research areas include lung modeling for predicting doses from inhaled particles, lung morphometry for growing mammals, health effects of inhaled air pollutants, and applied aerosol physics. He chaired the institutional review board (IRB) at UCI for seven years. He served on the National Research Council’s Committee on Animal Models for Testing Interventions Against Aerosolized Bioterrorism Agents. Dr. Phalen received a Ph.D. in biophysics, with specialization in inhalation toxicology, from the University of Rochester.
Hwashin H. Shin
Hwashin H. Shin is a Research Scientist in the Environmental Health Science and Research Bureau of Health Canada. She is also an adjunct professor in the Department of Mathematics and Statistics of Queen’s University in Ontario, Canada. Previously, she was a research associate at the Institute of Population Health at the University of Ottawa. Her research areas include environmental public health risk models, epidemiology, and experimental optimal design. Dr. Shin’s recent research topics include bias correction in estimation of public health risk attributable to short-term air pollution exposure, and the systematic review and meta-analysis of outdoor fine particles and strokes. Dr. Shin is a member of the Outdoor Air Pollution Committee of Global Burden Disease. She received a Ph.D. in statistics from Queen’s University.